WallStreetZenWallStreetZen

NASDAQ: MYNZ
Mainz Biomed Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their MYNZ stock forecasts and price targets.

Forecast return on equity

Is MYNZ forecast to generate an efficient return?
Company
-569.98%
Industry
-3.94%
Market
39.98%
MYNZ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MYNZ forecast to generate an efficient return on assets?
Company
-120.19%
Industry
8.76%
MYNZ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MYNZ earnings per share forecast

What is MYNZ's earnings per share in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.88

MYNZ revenue forecast

What is MYNZ's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.3M+45.17%

MYNZ vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MYNZ$0.25N/AN/A
MDXH$2.63N/AN/A
ISPC$4.74N/AN/A
PRPO$6.27N/AN/A
TRIB$1.28N/AN/A
View Top Diagnostic & Research Stocks

Mainz Biomed Nv Stock Forecast FAQ

What is MYNZ's earnings growth forecast for 2024-2024?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Mainz Biomed Nv's earnings in 2024 is -$26,295,727.

In 2024, MYNZ is forecast to generate -$18,519,797 in earnings, with the lowest earnings forecast at -$19,260,589 and the highest earnings forecast at -$17,779,005.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.

What is MYNZ's revenue growth forecast for 2024-2024?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Mainz Biomed Nv's revenue in 2024 is $895,479.

In 2024, MYNZ is forecast to generate $27,515,127 in revenue, with the lowest revenue forecast at $27,515,127 and the highest revenue forecast at $27,515,127.

What is MYNZ's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: MYNZ) forecast ROA is -120.19%, which is lower than the forecast US Diagnostics & Research industry average of 8.76%.

What is MYNZ's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: MYNZ) Mainz Biomed Nv's current Earnings Per Share (EPS) is -$1.62. In 2024, MYNZ's EPS is forecast to hit -$0.88 (min: -$0.91, max: -$0.84).

What is MYNZ's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: MYNZ) forecast ROE is -569.98%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.